{"id":31214,"date":"2017-05-11T11:54:42","date_gmt":"2017-05-11T09:54:42","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=31214"},"modified":"2017-05-11T18:57:02","modified_gmt":"2017-05-11T16:57:02","slug":"svizzera-sistema-sanitario-piace-costi-no-responsabile-lindustria-farmaceutica","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/svizzera-sistema-sanitario-piace-costi-no-responsabile-lindustria-farmaceutica\/","title":{"rendered":"Swiss. The health system likes it, the costs don&#039;t. Responsible: the pharmaceutical industry"},"content":{"rendered":"<h1 style=\"text-align: center;\"><span style=\"color: #ff0000;\">The health system likes it, the costs don&#039;t<\/span><\/h1>\n<h3>A survey reveals it - Marked differences between the population questioned and the group of &quot;opinion leaders&quot; on the causes of the explosion in costs and possible remedies<\/h3>\n<p>BERN \u2013 The Swiss appreciate the quality of the Swiss healthcare system, but criticize the constant increase in costs.<\/p>\n<p><img decoding=\"async\" class=\"alignright\" src=\"http:\/\/www.salutedomani.com\/immanager\/article\/front_no_125154.jpg\" alt=\"Risultati immagini per sistema sanitario elvetico\" \/>A survey published today - carried out on the Internet and in which 538 French-speaking, 538 Swiss-German and 206 Ticino-born took part - indicates that for the 21% of the sample the quality\/price ratio of the healthcare system is &quot;bad&quot; and for the 41% &quot;passable&quot; . As for the explosion in costs, the main culprits are identified in the pharmaceutical industry and the health insurance funds.<\/p>\n<p>The pollsters also consulted a group of &quot;opinion leaders&quot; - a total of 348 people including politicians, entrepreneurs and representatives of the economic, cultural and scientific worlds - and the results were varied: the quality\/price ratio was judged negatively by the 10%, \u201cpassable\u201d by 26%. As for the rising costs, two main causes have been indicated: the aging of the population and technological advances in medicine.<\/p>\n<p>Opinions were also divergent on the possible remedies: among the population, 67% said they were in favor of a single sickness fund and 52% stated that they shared the proposal to limit premiums to 10% of the insured&#039;s gross income. For the 65% of the &quot;leaders&quot; it would instead be necessary to reduce the number of public hospitals and increase the minimum deductibles from 300 to 500 francs. The idea of creating, on a voluntary basis, a &quot;health savings account&quot;, deductible from taxes, should also be evaluated.<\/p>\n<p>The poll was carried out between 13 and 18 March by the Lausanne polling institute MIS on behalf of the newspaper &quot;Le Temps&quot;.<\/p>\n<p><a href=\"http:\/\/www.cdt.ch\/svizzera\/cronaca\/176313\/il-sistema-sanitario-piace-i-costi-no\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"color: #0000ff;\"><em>TICINO COURIER<\/em> \u2013 May 10, 2017<\/span><\/a><\/p>\n<p>Related news: <a href=\"http:\/\/www.tio.ch\/News\/Svizzera\/Attualita\/1144822\/Comprare-i-farmaci-al-supermercato-presto-una-realta\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"color: #0000ff;\">Swiss. Buying drugs at the supermarket, soon a reality?<\/span><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Il sistema sanitario piace, i costi no Lo rivela un sondaggio &#8211; Marcate differenze tra la popolazione interpellata e il gruppo di &#8220;leader di opinione&#8221; sulle cause dell&#8217;esplosione dei costi e sui possibili rimedi BERNA &#8211; Gli svizzeri apprezzano la qualit\u00e0 del sistema sanitario elvetico, ma criticano la costante crescita dei costi. Un sondaggio pubblicato &hellip;<\/p>","protected":false},"author":4,"featured_media":5602,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[26],"class_list":["post-31214","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-spesa-farmaceutica"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/31214","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=31214"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/31214\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/5602"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=31214"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=31214"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=31214"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}